Clinical Trials Browser

Interventional × Cancer Pain × Ultracet × Clear all

NCT00576173 2010-04-28

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Phase 4 Completed

Cancer Pain, Pain, Breakthrough Pain